1. Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
   Qianyang Ni et al, 2022, Technology in Cancer Research & Treatment CrossRef
2. Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
   Dima A. Sabbah et al, 2024, Expert Opinion on Therapeutic Patents CrossRef
3. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
   Daniel J. Smit et al, 2020, Cells CrossRef
4. Lipid Messenger Phosphatidylinositol-4,5-Bisphosphate Is Increased by Both PPARα Activators and Inhibitors: Relevance for Intestinal Cell Differentiation
   Katerina Cizkova et al, 2022, Biology CrossRef
5. LncRNA CAI2 Contributes to Poor Prognosis of Glioma through the PI3K-Akt Signaling Pathway
   Yu Jiang et al, 2024, Combinatorial Chemistry & High Throughput Screening CrossRef